TD Cowen maintains Hold on Northrop Grumman, cuts target to $550

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

TD Cowen analyst Gautam Khanna has maintained a Hold rating on Northrop Grumman (NYSE: NOC) while lowering the price target from $580 to $550. The revised target reflects a revised valuation outlook.

powered bylight_fuzz_icon
46295646

*this image is generated using AI for illustrative purposes only.

TD Cowen analyst Gautam Khanna has maintained a Hold rating on Northrop Grumman (NYSE: NOC) while lowering the price target from $580 to $550. This adjustment reflects a revised valuation outlook for the defense contractor as the firm assesses its near-term market performance.

Rating and Price Target Details

The revised price target of $550 represents a decrease from the previous target of $580. The Hold rating indicates that the analyst expects the stock to perform in line with the market average over the near term.

Metric Value
Rating Hold
Previous Price Target $580
New Price Target $550

Northrop Grumman continues to be monitored for its operational performance and market position, which underpin the analyst's assessment.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors led to the downward revision of the valuation outlook?

How might Northrop Grumman's upcoming earnings report influence future analyst ratings?

What are the potential risks or opportunities in the defense sector that could impact the stock?

like16
dislike

Northrop Grumman raises 2026 guidance on record backlog

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Northrop Grumman reported Q2 2026 EPS of $7.68 on sales of $10.9 billion, surpassing analyst estimates. The company raised full-year sales guidance to $44 billion and increased EPS projections by $1.20, citing a record backlog of $105 billion and strong bookings, despite margin pressure from program adjustments in Space and Defense Systems.

powered bylight_fuzz_icon
46181244

*this image is generated using AI for illustrative purposes only.

Northrop Grumman reported second quarter 2026 earnings per share of $7.68, beating analyst estimates by 12.61%. Sales for the quarter reached $10.9 billion, surpassing the consensus estimate of $10.803 billion and rising 5% year-over-year. The company raised its full-year 2026 sales guidance to $44 billion and increased EPS projections by $1.20, supported by a record backlog of $105 billion and a book-to-bill ratio of 1.84.

Financial Performance Summary

The following table details Northrop Grumman's performance against analyst estimates and year-ago figures:

Metric Q2 Current Estimate Change vs Estimate Year-Ago Change vs Year-Ago
Sales $10.9 billion $10.803 billion +0.67% $10.350 billion +5.08%
EPS $7.68 $6.82 +12.61% $7.11 +8.02%

Operational Highlights and Guidance

Sales increased by 5% across all four business segments, though operating margins were impacted by negative estimates-at-completion (EAC) adjustments in the Space and Defense Systems segments. Specifically, the Space segment faced unfavorable adjustments on the GEM 63XL program, while Defense Systems saw higher projected costs on the Stand-in Attack Weapon (SiAW) program. Despite these pressures, the company generated $20 billion in net awards during the quarter.

Looking ahead, Northrop Grumman increased its full-year 2026 sales guidance to a range of $43.75 billion to $44.25 billion, representing over 5% organic growth. The company raised its adjusted EPS guidance to a range of $28.60 to $29.10, an increase of $1.20 at the midpoint. Management affirmed its adjusted free cash flow guidance of $3.1 billion to $3.5 billion. The record backlog and strong bookings provide visibility for accelerated sales growth in the second half of the year.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific measures is management taking to mitigate the cost overruns on the GEM 63XL and SiAW programs?

How sustainable is the current book-to-bill ratio of 1.84 given the record backlog, and what risks could impact future awards?

Will the margin pressures in the Space and Defense Systems segments persist into the second half of the year?

like19
dislike

More News on Northrop Grumman Corp